Identifying and treating renal artery stenosis in transplanted kidneys
Identification and Treatment of Renal Stenosis in Transplanted Kidneys
This study is testing if a new stenting treatment can help improve blood flow in transplanted kidneys for patients with narrowed renal arteries.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06822205 on ClinicalTrials.gov |
What this trial studies
This study focuses on evaluating the efficacy and safety of endovascular treatment, specifically stenting, for patients with renal artery stenosis following kidney transplantation. It aims to assess technical success and graft salvage rates, as well as the complication rates associated with this treatment. The study includes a retrospective phase analyzing data from January 2020 to April 2023, followed by a prospective phase that will continue for two years starting in May 2023.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have undergone kidney transplantation and have been diagnosed with renal artery stenosis.
Not a fit: Patients who do not have renal artery stenosis or those who are not kidney transplant recipients may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve outcomes for kidney transplant patients by effectively treating renal artery stenosis and potentially preventing transplant failure.
How similar studies have performed: Previous studies have shown success with endovascular treatments for renal artery stenosis, indicating that this approach is supported by existing literature.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater than or equal to 18 years * Indication of renal transplant and diagnosis of renal artery stenosis of the transplant * Obtaining informed consent Exclusion Criteria: \-
Where this trial is running
Bologna
- IRCCS AOU di Bologna Policlinico di Sant'Orsola — Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Mauro Gargiulo, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Mauro Gargiulo, MD
- Email: mauro.gargiulo2@unibo.it
- Phone: 0512143288
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.